Pioglitazone Combined with Insulin Linked to Higher Ischemic Heart Disease Risk in Type 2 Diabetes Patients: Study Reveals Medha Baranwal17 Dec 2024 9:00 AM ISTTaiwan: A recent study has found that administering pioglitazone with insulin to patients with type 2 diabetes mellitus (T2DM) inadequately controlled...
Combining SGLT2 Inhibitors and Pioglitazone May Reduce Risk of MASH in Type 2 Diabetes, Study Finds Medha Baranwal16 Nov 2024 8:15 AM ISTChina: A recent real-world study has revealed promising benefits from combining sodium-glucose co-transporter 2 inhibitors (SGLT2i) and pioglitazone...
Glipizide-Metformin, Glimepiride-Metformin-Pioglitazone FDCs Reduce Medication Costs in Indian T2DM: Study Dr. Kamal Kant Kohli27 May 2024 11:30 AM ISTAffordable combination medicines, such as glipizide + metformin and glimepiride + metformin + pioglitazone offer considerable advantages and can...
Affordable Combinations in T2DM care: Scope of Glipizide, Metformin and Glimepiride, Metformin, Pioglitazone MDTV Bureau20 May 2024 11:31 AM ISTDual therapy of Glipizide + Metformin and the triple drug combination of Glimepiride + Metformin + Pioglitazone emerges as effective, safe, and...
Pioglitazone add-on therapy in patients with type 2 diabetes effective and safe option for better glycemic control: Study Medha Baranwal10 April 2024 10:00 AM ISTSouth Korea: Adjunctive pioglitazone therapy in type 2 diabetes mellitus (T2DM) inadequately controlled with dapagliflozin and metformin yielded...
CDSCO nod to Synokem Pharma for marketing, manufacturing antidiabetic FDC Pioglitazone, Vildagliptin Isra Zaman4 Sept 2023 2:21 PM ISTWith the condition of conducting phase IV clinical trial, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Health Bulletin 02/September/2023 Isra Zaman2 Sept 2023 4:19 PM ISTHere are the Top health stories for the day:Death of pregnant doctor due to delayed medical attention: HC sets aside WBCERC order, directs...
Synokem Gets CDSCO Panel Nod To Manufacture, Market antidiabetic FDC Pioglitazone, Vildagliptin Dr. Divya Colin31 Aug 2023 6:00 PM ISTNew Delhi: With the condition of conducting phase IV clinical trial, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
ADA Releases Guidelines Update for Screening and Treatment NAFLD in Type 2 Diabetes, Check Out Details Dr. Kamal Kant Kohli28 July 2023 11:32 AM ISTUnderstanding the close interaction between Non-Alcoholic Fatty Liver Disease & Type 2 Diabetes, and continuously evolving evidence, the American...
Akums gets approval for triple combination diabetes treatment Ruchika Sharma27 July 2023 4:50 PM ISTDelhi: Akums Drugs and Pharmaceuticals Limited has secured approval for its triple combination diabetes treatment. Sitagliptin 100, Pioglitazone 15...
American Diabetes Association releases guideline update on NAFLD in People with diabetes MD Brand Connect13 July 2023 11:15 AM ISTPioglitazone/GLP1 RA are the preferred agents for the treatment of hyperglycemia in people with T2DM diabetes with NAFLD or those at high risk of...
Akums Pharma Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Drug Dr. Divya Colin9 July 2023 6:00 PM ISTNew Delhi: Noting that the antidiabetic fixed-dose combination (FDC), Sitagliptin Phosphate Monohydrate 100mg/100mg plus Pioglitazone 15mg/15mg plus...
